MGH, NeuroLogica to Pilot Photon Counting Computed Tomography at the Point-Of-Care

By News Release

Massachusetts General Hospital (MGH) will pilot NeuroLogica Corp.’s OmniTom Elite with Photon Counting Detector (PCD) technology at the point of care to evaluate the technology’s ability to diagnose and initiate treatment for patients in the ICU. Pending FDA 510(k) clearance of this technology, MGH will pilot test the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients. During the pilot of the OmniTom Elite with PCD, Massachusetts General Hospital will guide best practices and evaluate use cases for the novel system.

"We are excited about our collaboration with NeuroLogica,” said Raj Gupta, MD, PhD, Director, Ultra-High-Resolution Volume CT Lab, Massachusetts General Hospital. “This will be the first time where multi-spectral imaging will be used inside of the intensive care unit. We are particularly interested in how this technology can help guide patient care decisions through quantitative image analysis.”

Photon counting is a CT technology that sorts the different energies of X-rays after they have passed through the scan field. The multiple sets of CT data are acquired at the same time with configurable energy thresholds. This could potentially mean more accurate visualization and segmentation of bone, blood clots, plaque, hemorrhage, and intracranial tumor in critical intensive care unit (ICU) patients when in use with the OmniTom Elite scanner. As well, PCD has the potential to fundamentally change the use of injected contrast agents that highlight blood vessels by collecting high signal even at low contrast agent dosage. PCD provides the ability to capture CT data in multiple energy bands that can provide information on material composition of different tissues and contrast media.

“Since the advent of point-of-care CT in 2004 by NeuroLogica, we have always known that point-of-care imaging can improve patient outcomes and increase the likelihood of a better post-traumatic quality of life,” said David Webster, Chief Operating O􀀁icer of NeuroLogica. “With the introduction of Photon Counting to the OmniTom Elite platform, we hope to expand the diagnostic possibilities of computed tomography at the patient’s bedside.”

Back To Top

MGH, NeuroLogica to Pilot Photon Counting Computed Tomography at the Point-Of-Care.  Appl Radiol. 

By News Release| July 14, 2021

About the Author

News Release

News Release



Copyright © Anderson Publishing 2021